Integer Holdings Corporation (NYSE:ITGR) Receives $140.25 Average Target Price from Brokerages

Shares of Integer Holdings Corporation (NYSE:ITGR) have earned an average rating of “Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $139.5714.

ITGR has been the topic of a number of recent analyst reports. Raymond James Financial lowered their target price on Integer from $150.00 to $143.00 and set an “outperform” rating on the stock in a research note on Friday, July 25th. Wall Street Zen upgraded Integer from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Truist Financial lowered their target price on Integer from $145.00 to $137.00 and set a “buy” rating on the stock in a research note on Friday, July 25th. Finally, Wells Fargo & Company lowered their price objective on Integer from $152.00 to $132.00 and set an “overweight” rating on the stock in a research note on Friday, July 25th.

Integer Price Performance

ITGR opened at $103.13 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The company has a market capitalization of $3.61 billion, a price-to-earnings ratio of 45.43, a P/E/G ratio of 0.81 and a beta of 0.97. The firm’s fifty day moving average price is $105.71 and its two-hundred day moving average price is $114.18. Integer has a 1 year low of $99.73 and a 1 year high of $146.36.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million for the quarter, compared to analysts’ expectations of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.Integer’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, analysts anticipate that Integer will post 6.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Integer

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Opal Wealth Advisors LLC purchased a new position in shares of Integer during the first quarter worth about $28,000. AdvisorNet Financial Inc purchased a new position in shares of Integer during the first quarter worth about $28,000. Bessemer Group Inc. boosted its stake in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 125 shares in the last quarter. SVB Wealth LLC purchased a new stake in Integer in the first quarter worth approximately $35,000. Finally, CWM LLC boosted its stake in Integer by 46.1% in the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 112 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.